Cellid, COVID-19 vaccine Korean stock

已更新
Bullish

Reasons
- Cup & handle formation
- Bounces on trendline
- Currently developing COVID-19 vaccine in Korea alongside other biotech products
- Korean government granted $30 mil to develop vaccines recently
交易進行
Prices pulled back from the initial trendline due to choppiness from falling KOSDAQ index. This was due to fears of economic shutdown from COVID-19 breakouts.

Still a go. It still has not announced a clinical trial for the COVID-19 vaccine but received money from the Korean government to develop one. If it is announced, then it is going to rocket.
交易進行
Space elevator~
交易結束:達到停損點
Events didn't pan out as I had expected.

Too bad.
Technical IndicatorsTrend Analysis

更多:

免責聲明